Breakthrough Technologies for Brain Health
Our mission is to catalyze the commercial development of groundbreaking neuroscience to transform lives and revolutionize industries
Shaping the Future of Neuroscience with Deep Technology
From silicon to synapses, we believe the brain is the next major platform across life science and technology, and invest in companies that access and leverage neural data to accelerate breakthroughs.
AI/Data Analytics
Diagnostics
Biosensors
Neuroimaging
Neurostimulation
Drug Discovery
Not Just Investors- Neurotech Pioneers
Led by Dr. Ariane Tom, the firm leverages the expertise of world-class scientists, physicians, and policy leaders who have dedicated their careers to emerging technology for neuroscience innovation.
Kaleida Capital in the News
-
![Raise Global Summit]()
Kaleida selected as top 100 out of 700+ managers to attend RAISE Global Summit 2023, GP Panelist: "Frontiers of Deeptech"
-
![]()
Kaleida to speak at NANS Annual Meeting in 2024: "Funding Outlook for Neuromodulation Startups "
-
![]()
Kaleida awarded $100k grant funding as one of 36 emerging fund managers for inaugural Recast Accelerate Program
-
![]()
Kaleida releases publication with the Bakar Institute for Public Policy: "7 Steps for Igniting Brain Capital Industrial Strategy"
-
![]()
Kaleida invited to present at the Caltech Entrepreneur's Forum on Brain Computer Interfaces
Be part of the Neurotech Revolution
Kaleida Capital is the premier early stage venture capital firm dedicated to neurotechnology.
Join us to set the standard for brain health innovation.